Mutual of America Capital Management LLC Raises Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Mutual of America Capital Management LLC raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 2.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 97,994 shares of the pharmacy operator’s stock after purchasing an additional 2,127 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $3,714,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in WBA. FDx Advisors Inc. lifted its holdings in Walgreens Boots Alliance by 14.3% during the first quarter. FDx Advisors Inc. now owns 55,251 shares of the pharmacy operator’s stock valued at $2,474,000 after purchasing an additional 6,903 shares in the last quarter. Metis Global Partners LLC lifted its holdings in shares of Walgreens Boots Alliance by 83.0% in the first quarter. Metis Global Partners LLC now owns 11,467 shares of the pharmacy operator’s stock worth $513,000 after buying an additional 5,200 shares in the last quarter. Venture Visionary Partners LLC lifted its holdings in shares of Walgreens Boots Alliance by 3.8% in the first quarter. Venture Visionary Partners LLC now owns 12,722 shares of the pharmacy operator’s stock worth $569,000 after buying an additional 464 shares in the last quarter. Benedict Financial Advisors Inc. lifted its holdings in shares of Walgreens Boots Alliance by 2.1% in the first quarter. Benedict Financial Advisors Inc. now owns 48,817 shares of the pharmacy operator’s stock worth $2,186,000 after buying an additional 995 shares in the last quarter. Finally, Arizona State Retirement System lifted its holdings in shares of Walgreens Boots Alliance by 0.3% in the first quarter. Arizona State Retirement System now owns 201,895 shares of the pharmacy operator’s stock worth $9,039,000 after buying an additional 527 shares in the last quarter. Hedge funds and other institutional investors own 57.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Royal Bank of Canada lowered their target price on shares of Walgreens Boots Alliance from $42.00 to $36.00 and set a “sector perform” rating on the stock in a report on Wednesday, October 19th. Mizuho lowered their target price on shares of Walgreens Boots Alliance to $36.00 in a report on Thursday, October 13th. JPMorgan Chase & Co. raised shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $42.00 target price on the stock in a report on Friday. StockNews.com downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Wednesday, October 5th. Finally, Credit Suisse Group lowered their target price on shares of Walgreens Boots Alliance from $43.00 to $42.00 and set a “neutral” rating on the stock in a report on Friday, October 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $42.54.

Walgreens Boots Alliance Trading Down 0.9 %

WBA stock opened at $39.75 on Monday. The company has a quick ratio of 0.38, a current ratio of 0.75 and a debt-to-equity ratio of 0.36. Walgreens Boots Alliance, Inc. has a twelve month low of $30.39 and a twelve month high of $55.00. The stock has a market capitalization of $34.38 billion, a price-to-earnings ratio of 7.95, a price-to-earnings-growth ratio of 1.77 and a beta of 0.71. The firm’s fifty day simple moving average is $35.00 and its two-hundred day simple moving average is $38.14.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its quarterly earnings data on Thursday, October 13th. The pharmacy operator reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.03. Walgreens Boots Alliance had a net margin of 3.27% and a return on equity of 14.39%. The business had revenue of $32.45 billion for the quarter, compared to analysts’ expectations of $32.17 billion. During the same quarter in the previous year, the business posted $1.17 earnings per share. The business’s revenue was down 5.3% compared to the same quarter last year. As a group, analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Tuesday, November 15th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a yield of 4.83%. The ex-dividend date is Monday, November 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 38.40%.

About Walgreens Boots Alliance

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.